Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 α (HIF-1α) activity: involvement in myeloma-induced angiogenesis

Blood (2007) 110 (13): 4464–4475.

https://doi.org/10.1182/blood-2007-02-074617

Published: 2007

Journal Articles

Macrophage Inflammatory Protein (MIP)-3α/CCL20 and Its Receptor CCR6 Are Overexpressed in the Bone Microenvironment and Involved in Osteoclast Formation in Multiple Myeloma Patients.

Nicola Giuliani, MD, PhD, Gina Lisignoli, PhD, Sara Tagliaferri, Mirca Lazzaretti, PhD, Francesca Morandi, Simona Colla, PhD, Cristina Manferdini, Beatrice Tonnarelli, Vittorio Rizzoli, MD, PhD

Blood (2007) 110 (11): 3510.

https://doi.org/10.1182/blood.V110.11.3510.3510

Published: 2007

Journal Articles

Gene Expression Profiling of Isolated Mesenchymal and Osteoblastic Cells Exhibits a Different Pattern of Expression in Multiple Myeloma Patients as Compared to Healthy Subjects: Potential Relationship with the Presence of Bone Lesions.

Nicola Giuliani, Katia Todoerti, Gina Lisignoli, Sara Tagliaferri, Luca Agnelli, Francesca Morandi, Simona Colla, Monica Crugnola, Marina Magnani, Cecilia Caramatti, Marcellina Mangoni, Giorgio Lambertenghi Deliliers, Vittorio Rizzoli, Antonino Neri

Blood (2007) 110 (11): 3513.

https://doi.org/10.1182/blood.V110.11.3513.3513

Published: 2007

Journal Articles

Targeting MEK/MAPK Signal Transduction Module Potentiates Arsenic Trioxide (ATO)-Induced Apoptosis in Multiple Myeloma Cells through Multiple Signaling Pathways.

Paolo Lunghi, Nicola Giuliani, Laura Mazzera, Francesca Morandi, Luigi Salvatore, Marcellina Mangoni, Vittorio Rizzoli, Antonio Bonati

Blood (2007) 110 (11): 1517.

https://doi.org/10.1182/blood.V110.11.1517.1517

Published: 2007

Journal Articles

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients

Nicola Giuliani, Francesca Morandi, Sara Tagliaferri, Mirca Lazzaretti, Sabrina Bonomini, Monica Crugnola, Cristina Mancini, Eugenia Martella, Luca Ferrari, Antonio Tabilio, Vittorio Rizzoli

Blood (2007) 110 (1): 334–338.

https://doi.org/10.1182/blood-2006-11-059188

Published: 2007

Journal Articles

MEK1 Blockade Sensitizes Multiple Myeloma Tumor Cells to Arsenic Trioxide (ATO)-Induced Apoptosis: A Functional and Molecular Study.

Paolo Lunghi, PhD, Nicola Giuliani, MD, Laura Mazzera, PhD, Francesca Morandi, PhD, Vittorio Rizzoli, MD, Antonio Bonati, MD

Blood (2006) 108 (11): 1372.

https://doi.org/10.1182/blood.V108.11.1372.1372

Published: 2006

Journal Articles

Mesenchymal and Osteoblastic Cells Isolated from Multiple Myeloma Patients Reveal a Different Behavior, Phenotype and Gene Expression Profiling in Relationship with the Presence of Osteolytic Bone Lesions.

Nicola Giuliani, MD, PhD, Gina Lisignoli, PHD, Katia Todoerti, PHD, Sara Tagliaferri, Cristina Manferdini, Beatrice Tonnarelli, Luca Agnelli, PHD, Francesca Morandi, Monica Crugnola, MD, Giorgio Lambertenghi Deliliers, MD, Vittorio Rizzoli, MD, PHD, Antonino Neri, MD, PHD

Blood (2006) 108 (11): 3511.

https://doi.org/10.1182/blood.V108.11.3511.3511

Published: 2006

Journal Articles

Beta-Catenin Depended and Independent Effects Induced by Myeloma Cells in Human and Murine Osteoblasts and Osteoblast Progenitors.

Francesca Morandi, Sara Tagliaferri, Sabrina Bonomini, Mirca Lazzaretti, Luca Ferrari, Vittorio Rizzoli, Nicola Giuliani

Blood (2006) 108 (11): 3433.

https://doi.org/10.1182/blood.V108.11.3433.3433

Published: 2006

Journal Articles

DKK-1 and sFRP-3 Expression by Myeloma Cell and Bone Marrow Plasma Levels in Multiple Myeloma and MGUS Patients: Potential Relationship with Bone Status.

Nicola Giuliani, Francesca Morandi, Sara Tagliaferri, Luca Agnelli, Katia Todoerti, Mario Pedrazzoni, Monica Crugnola, Giorgio Lambertenghi Deliliers, Vittorio Rizzoli, Antonino Neri

Blood (2006) 108 (11): 3437.

https://doi.org/10.1182/blood.V108.11.3437.3437

Published: 2006

Journal Articles

p29ING4 Regulates the Production of Pro-Angiogenic Molecules by Human Myeloma Cells in Normoxic and Hypoxic Conditions Being Involved in Myeloma-Induced Angiogenesis.

Sara Tagliaferri, Francesca Morandi, Paolo Lunghi, Simona Colla, Mirca Lazzaretti, Cristina Mancini, Daniela Drandi, Marco Ladetto, Antonio Bonati, Vittorio Rizzoli, Nicola Giuliani

Blood (2006) 108 (11): 515.

https://doi.org/10.1182/blood.V108.11.515.515

Published: 2006

Journal Articles

The Proteasome Inhibitor Bortezomib Affects Osteoblastogenesis and Bone Formation In Vitro and In Vivo in Multiple Myeloma Patients.

Nicola Giuliani, MD, PhD, Francesca Morandi, Sara Tagliaferri, Mirca Lazzaretti, PHD, Sabrina Bonomini, Monica Crugnola, MD, Daniela Petrò, MD, Cristina Mancini, MD, Eugenia Martella, MD, Vittorio Rizzoli, MD, PHD

Blood (2006) 108 (11): 508.

https://doi.org/10.1182/blood.V108.11.508.508

Published: 2006

Journal Articles

Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients

Nicola Giuliani, Francesca Morandi, Sara Tagliaferri, Simona Colla, Sabrina Bonomini, Gabriella Sammarelli, Vittorio Rizzoli

Blood (2006) 107 (2): 841–842.

https://doi.org/10.1182/blood-2005-07-2719

Published: 2006

Journal Articles

Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis.

Nicola Giuliani, Simona Colla, Francesca Morandi, Sabrina Bonomini, Mirca Lazzaretti, Cristina Mancini, Monica Crugnola, Sara Tagliaferri, Rita Rizzato, Eugenia Martella, Gabriella Sammarelli, Luisa Craviotto, Cecilia Caramatti, Marcellina Mangoni, Vittorio Rizzoli

Blood (2005) 106 (11): 2501.

https://doi.org/10.1182/blood.V106.11.2501.2501

Published: 2005

Journal Articles

The Candidate Tumor Suppressor p29ING4 Is Down-Regulated in Human Myeloma Cells and Involved in Their Pro-Angiogenic Properties.

Nicola Giuliani, Francesca Morandi, Simona Colla, Sara Tagliaferri, Mirca Lazzaretti, Gabriella Sammarelli, Cristina Mancini, Sabrina Bonomini, Vittorio Rizzoli

Blood (2005) 106 (11): 2502.

https://doi.org/10.1182/blood.V106.11.2502.2502

Published: 2005

Journal Articles

Effects of Human Myeloma Cells on WNT Signaling System in Human Bone Marrow Osteoprogenitor Cells.

Nicola Giuliani, Francesca Morandi, Rita Rizzato, Sara Tagliaferri, Vittorio Rizzoli

Blood (2005) 106 (11): 2503.

https://doi.org/10.1182/blood.V106.11.2503.2503

Published: 2005

Journal Articles

Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation

Nicola Giuliani, Simona Colla, Francesca Morandi, Mirca Lazzaretti, Roberto Sala, Sabrina Bonomini, Maria Grano, Silvia Colucci, Mirija Svaldi, Vittorio Rizzoli

Blood (2005) 106 (7): 2472–2483.

https://doi.org/10.1182/blood-2004-12-4986

Published: 2005

Journal Articles

IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

Lori A. Ehrlich, Ho Yeon Chung, Irene Ghobrial, Sun Jin Choi, Francesca Morandi, Simona Colla, Vittorio Rizzoli, G. David Roodman, Nicola Giuliani

Blood (2005) 106 (4): 1407–1414.

https://doi.org/10.1182/blood-2005-03-1080

Published: 2005

Journal Articles

Myeloma Cells Block Runx2/Cbfa1 Activity in Human Bone Marrow Osteoblast Progenitors and Inhibit Osteoblast Formation and Differentiation.

Nicola Giuliani, MD, PhD, Simona Colla, PhD, Francesca Morandi, PhD, Sabrina Bonomini, PhD, Vittorio Rizzoli, MD, PhD

Blood (2004) 104 (11): 632.

https://doi.org/10.1182/blood.V104.11.632.632

Published: 2004

Journal Articles

Human Myeloma Cells Express the Bone Regulating Gene Runx2/Cbfa1 and Produce Osteopontin That It Is Involved in Myeloma-Induced Angiogenesis.

Nicola Giuliani, MD, PhD, Simona Colla, PhD, Francesca Morandi, PhD, Sabrina Bonomini, PhD, Monica Crugnola, MD, Vittorio Rizzoli, MD, PhD

Blood (2004) 104 (11): 2344.

https://doi.org/10.1182/blood.V104.11.2344.2344

Published: 2004

Journal Articles

Do human myeloma cells directly produce basic FGF?

Simona Colla, Francesca Morandi, Mirca Lazzaretti, Paola Polistena, Mirija Svaldi, Paolo Coser, Sabrina Bonomini, Magda Hojden, Eugenia Martella, Teodoro Chisesi, Vittorio Rizzoli, Nicola Giuliani

Blood (2003) 102 (8): 3071–3073.

https://doi.org/10.1182/blood-2003-06-1883

Published: 2003

NARROW

The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 α (HIF-1α) activity: involvement in myeloma-induced angiogenesis

Macrophage Inflammatory Protein (MIP)-3α/CCL20 and Its Receptor CCR6 Are Overexpressed in the Bone Microenvironment and Involved in Osteoclast Formation in Multiple Myeloma Patients.

Gene Expression Profiling of Isolated Mesenchymal and Osteoblastic Cells Exhibits a Different Pattern of Expression in Multiple Myeloma Patients as Compared to Healthy Subjects: Potential Relationship with the Presence of Bone Lesions.

Targeting MEK/MAPK Signal Transduction Module Potentiates Arsenic Trioxide (ATO)-Induced Apoptosis in Multiple Myeloma Cells through Multiple Signaling Pathways.

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients

MEK1 Blockade Sensitizes Multiple Myeloma Tumor Cells to Arsenic Trioxide (ATO)-Induced Apoptosis: A Functional and Molecular Study.

Mesenchymal and Osteoblastic Cells Isolated from Multiple Myeloma Patients Reveal a Different Behavior, Phenotype and Gene Expression Profiling in Relationship with the Presence of Osteolytic Bone Lesions.

Beta-Catenin Depended and Independent Effects Induced by Myeloma Cells in Human and Murine Osteoblasts and Osteoblast Progenitors.

DKK-1 and sFRP-3 Expression by Myeloma Cell and Bone Marrow Plasma Levels in Multiple Myeloma and MGUS Patients: Potential Relationship with Bone Status.

p29ING4 Regulates the Production of Pro-Angiogenic Molecules by Human Myeloma Cells in Normoxic and Hypoxic Conditions Being Involved in Myeloma-Induced Angiogenesis.

The Proteasome Inhibitor Bortezomib Affects Osteoblastogenesis and Bone Formation In Vitro and In Vivo in Multiple Myeloma Patients.

Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients

Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis.

The Candidate Tumor Suppressor p29ING4 Is Down-Regulated in Human Myeloma Cells and Involved in Their Pro-Angiogenic Properties.

Effects of Human Myeloma Cells on WNT Signaling System in Human Bone Marrow Osteoprogenitor Cells.

Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation

IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

Myeloma Cells Block Runx2/Cbfa1 Activity in Human Bone Marrow Osteoblast Progenitors and Inhibit Osteoblast Formation and Differentiation.

Human Myeloma Cells Express the Bone Regulating Gene Runx2/Cbfa1 and Produce Osteopontin That It Is Involved in Myeloma-Induced Angiogenesis.

Do human myeloma cells directly produce basic FGF?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only